ustransplant.org

Transplant Statistics: Annual Report : Reference Tables

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Table 12.6a
Immunosuppression Use for Induction, 1992 to 2001
Recipients with Lung Transplants

  Year of Transplant
1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
Transplants 535 674 738 893 832 946 891 918 971 1,071
Tx With Immunosuppression Info 531 666 731 880 759 927 878 893 937 1,009
No Induction Drugs Recorded 94.9% 97.0% 75.0% 71.5% 73.6% 78.1% 80.1% 71.1% 56.9% 60.6%
Drugs - - 0.0% 0.0% - - - - - -
ALG
ATG 1.1% 0.8% 18.9% 23.2% 20.6% 17.6% 12.3% 11.6% 11.4% 8.6%
NRATG/NRATS - - 0.0% 0.1% 2.2% 2.0% 1.7% 1.0% 0.6% -
OKT3 4.0% 2.3% 6.2% 5.2% 3.7% 2.5% 3.4% 3.4% 2.7% 1.1%
Thymoglobulin - - - - - - - 1.9% 6.1% 5.5%
Zenapax - - - - - - 2.6% 8.7% 14.4% 11.3%
Simulect 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.5% 8.3% 13.5%

Source: OPTN/SRTR Data as of August 1, 2002.
(-) = Drug not used anytime during the year.
Induction drugs include any reported antilymphocyte antibodies and antibodies directed against lymphocyte
receptors.

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline

Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map

SRTR Site designed and maintained by Diamond Bullet Design & URREA.